FI960998L - N-(3-bentsofuranyyli)ureajohdannaisia - Google Patents

N-(3-bentsofuranyyli)ureajohdannaisia Download PDF

Info

Publication number
FI960998L
FI960998L FI960998A FI960998A FI960998L FI 960998 L FI960998 L FI 960998L FI 960998 A FI960998 A FI 960998A FI 960998 A FI960998 A FI 960998A FI 960998 L FI960998 L FI 960998L
Authority
FI
Finland
Prior art keywords
benzofuranyl
urea derivatives
urea
derivatives
Prior art date
Application number
FI960998A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI960998A7 (fi
FI960998A0 (fi
Inventor
Gabriele Braeunlich
Ruediger Fischer
Mazen Es-Sayed
Rolf Henning
Michael Sperzel
Karl-Heinz Schlemmer
Ulrich Nielsch
Stephen Tudhope
Graham Sturton
Trevor S Abram
Mary F Fitzgerald
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI960998A0 publication Critical patent/FI960998A0/fi
Publication of FI960998A7 publication Critical patent/FI960998A7/fi
Publication of FI960998L publication Critical patent/FI960998L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Cosmetics (AREA)
FI960998A 1995-03-06 1996-03-04 N-(3-bentsofuranyyli)ureajohdannaisia FI960998L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9504460.8A GB9504460D0 (en) 1995-03-06 1995-03-06 N-(3-Benzofuranyl)urea-derivatives

Publications (3)

Publication Number Publication Date
FI960998A0 FI960998A0 (fi) 1996-03-04
FI960998A7 FI960998A7 (fi) 1996-09-07
FI960998L true FI960998L (fi) 1996-09-07

Family

ID=10770709

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960998A FI960998L (fi) 1995-03-06 1996-03-04 N-(3-bentsofuranyyli)ureajohdannaisia

Country Status (41)

Country Link
US (2) US6399657B1 (de)
EP (1) EP0731099B1 (de)
JP (1) JP3204901B2 (de)
KR (2) KR100405579B1 (de)
CN (2) CN1176651C (de)
AR (1) AR002710A1 (de)
AT (1) ATE193704T1 (de)
BG (2) BG62732B1 (de)
BR (1) BR9600930A (de)
CA (1) CA2170824A1 (de)
CO (1) CO4370145A1 (de)
CZ (1) CZ66796A3 (de)
DE (1) DE69608721T2 (de)
DK (1) DK0731099T3 (de)
DZ (1) DZ1998A1 (de)
EE (1) EE03921B1 (de)
ES (1) ES2147320T3 (de)
FI (1) FI960998L (de)
GB (1) GB9504460D0 (de)
GR (1) GR3034240T3 (de)
HR (1) HRP960071B1 (de)
HU (1) HU222282B1 (de)
IL (1) IL117349A (de)
MA (1) MA23815A1 (de)
MY (1) MY117526A (de)
NO (1) NO313672B1 (de)
NZ (1) NZ286107A (de)
PE (1) PE43597A1 (de)
PL (1) PL189206B1 (de)
PT (1) PT731099E (de)
RO (1) RO116622B1 (de)
RU (1) RU2162845C2 (de)
SI (1) SI0731099T1 (de)
SK (1) SK281817B6 (de)
SV (1) SV1996000015A (de)
TN (1) TNSN96035A1 (de)
TR (1) TR199600177A2 (de)
TW (1) TW336934B (de)
UA (1) UA46714C2 (de)
YU (1) YU49359B (de)
ZA (1) ZA961774B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
GB9525262D0 (en) * 1995-12-11 1996-02-07 Bayer Ag Heterocyclylcarbonyl substituted benzofuranyl-ureas
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
GB9614718D0 (en) 1996-07-12 1996-09-04 Bayer Ag 3-ureido-pyridofurans and -pyridothiophenes
JPH10168095A (ja) 1996-12-10 1998-06-23 Cci Corp 炎症性腸疾患予防および治療剤
EP1129068A1 (de) * 1998-11-12 2001-09-05 Ariad Pharmaceuticals, Inc. Bizyclische inhibitoren von signal-transduktion, sie enthaltende zusammensetzungen und ihre verwendungen
GB2350112A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active cycloalkyl ketones
GB2350111A (en) * 1999-05-17 2000-11-22 Bayer Ag Oligohydroxyl substituted 3-urea-benzofuran and pyridofuran derivatives
GB2350110A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active benzofurans
GB2350109A (en) 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active benzofuranyl sulfonates
US7144885B2 (en) 2002-02-22 2006-12-05 Bayer Pharmaceuticals Corporation Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
AU2003215380B2 (en) 2002-02-22 2008-10-02 Bayer Pharmaceuticals Corporation Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
CN1738797A (zh) 2002-11-19 2006-02-22 阿基里昂药品公司 取代的芳基硫脲和相关的化合物,病毒复制的抑制剂
US7186725B2 (en) 2003-01-03 2007-03-06 Genzyme Corporation Anti-inflammatory compositions and methods
TW200528459A (en) * 2004-01-06 2005-09-01 Achillion Pharmaceuticals Inc Azabenzofuran substituted thioureas; inhibitors of viral replication
TW200600492A (en) * 2004-05-18 2006-01-01 Achillion Pharmaceuticals Inc Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
WO2006137350A1 (ja) * 2005-06-22 2006-12-28 Kissei Pharmaceutical Co., Ltd. 新規なフロピリジン誘導体、それを含有する医薬組成物およびそれらの用途
PT2359826E (pt) 2006-07-05 2014-01-20 Takeda Gmbh Combinação de um inibidor da hmg-coa redutase rosuvastatina e um inibidor da fosfodiesterase 4, tais como roflumilaste, óxido de n-roflumilaste, para o tratamento de doenças pulmonares inflamatórias
EP2685975A1 (de) 2011-03-17 2014-01-22 Algiax Pharmaceuticals GmbH Neue verwendung von benzofuranylsulfonaten
WO2013156232A1 (en) * 2012-04-16 2013-10-24 Algiax Pharmaceuticals Gmbh Use of benzofuranylsulfonates in neuropathic pain
WO2015140081A1 (en) 2014-03-18 2015-09-24 Algiax Pharmaceuticals Gmbh 2-cyano-3-cyclopropyl-3-hydroxy-n-aryl-thioacrylamide derivatives
EP3165224A1 (de) 2015-11-09 2017-05-10 Albert-Ludwigs-Universität Freiburg Verwendung von pde4 hemmern zur prophylaxe und/oder therapie von dyslipoproteinaemie und verwandten erkrankungen
WO2017089347A1 (en) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas
JP6788966B2 (ja) * 2015-12-24 2020-11-25 丸善製薬株式会社 化粧料
EP4020024A1 (de) 2020-12-22 2022-06-29 Paul Scherrer Institut Verfahren zur herstellung einer fächerförmigen optik mit hohem aspektverhältnis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1382742A (en) * 1972-09-19 1975-02-05 Labaz Benzofuran derivatives and process for preparing the same
GB1464242A (en) * 1974-04-18 1977-02-09 Smithkline Corp Benzoyl benzofurans and compositions comprising them
AU559687B2 (en) * 1981-07-01 1987-03-19 Upjohn Company, The Pyridinyl-and imidazolyl-benzofurane and benzothiophenes
US4663347A (en) 1983-10-31 1987-05-05 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis
US4933351A (en) * 1983-10-31 1990-06-12 Merck Frosst Canada, Inc. Benzofuran 2-carbox amides useful as inhibitors of leukoriene biosynthesis
US4822803A (en) * 1983-10-31 1989-04-18 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid hydrazides useful as inhibitors of leukotriene biosynthesis
EP0146243A1 (de) * 1983-10-31 1985-06-26 Merck Frosst Canada Inc. Lipoxygenase-Inhibitoren
US5087638A (en) * 1984-06-20 1992-02-11 Merck Frosst Canada, Inc. Benzofuran derivatives
US4703053A (en) * 1985-10-28 1987-10-27 Warner-Lambert Company Benzothiophenes and benzofurans and antiallergic use thereof
GB9200623D0 (en) * 1992-01-13 1992-03-11 Bayer Ag Benzofuranyl and thiophenyl-methylthio-alkanecarboxylic acid derivatives
GB9309324D0 (en) * 1993-05-06 1993-06-16 Bayer Ag Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives

Also Published As

Publication number Publication date
HRP960071A2 (en) 1997-12-31
HUP9600549A2 (en) 1997-07-28
DE69608721T2 (de) 2000-10-05
BR9600930A (pt) 1997-12-30
DK0731099T3 (da) 2000-09-25
NO313672B1 (no) 2002-11-11
TNSN96035A1 (fr) 2005-03-15
NZ286107A (en) 1998-08-26
CZ66796A3 (en) 1996-09-11
BG62732B1 (bg) 2000-06-30
NO960884D0 (no) 1996-03-05
HK1013285A1 (en) 1999-08-20
YU49359B (sh) 2005-09-19
IL117349A0 (en) 1996-07-23
EE9600030A (et) 1996-10-15
SK29796A3 (en) 1996-10-02
IL117349A (en) 2002-09-12
SK281817B6 (sk) 2001-08-06
CN1313284A (zh) 2001-09-19
MY117526A (en) 2004-07-31
EP0731099B1 (de) 2000-06-07
ZA961774B (en) 1996-09-17
PE43597A1 (es) 1997-12-26
KR960034194A (ko) 1996-10-22
JPH08253466A (ja) 1996-10-01
JP3204901B2 (ja) 2001-09-04
ATE193704T1 (de) 2000-06-15
CA2170824A1 (en) 1996-09-07
AR002710A1 (es) 1998-04-29
GR3034240T3 (en) 2000-12-29
DE69608721D1 (de) 2000-07-13
KR100438633B1 (ko) 2004-07-02
YU13396A (sh) 1999-06-15
PL189206B1 (pl) 2005-07-29
HUP9600549A3 (en) 1998-04-28
BG100396A (bg) 1996-12-31
CN1134419A (zh) 1996-10-30
GB9504460D0 (en) 1995-04-26
HU9600549D0 (en) 1996-04-29
CN1176651C (zh) 2004-11-24
DZ1998A1 (fr) 2002-07-20
HRP960071B1 (en) 2001-04-30
AU705667B2 (en) 1999-05-27
US20030109578A1 (en) 2003-06-12
US6399657B1 (en) 2002-06-04
HU222282B1 (hu) 2003-05-28
TR199600177A2 (tr) 1996-10-21
RU2162845C2 (ru) 2001-02-10
CO4370145A1 (es) 1996-10-07
PL313070A1 (en) 1996-09-16
RO116622B1 (ro) 2001-04-30
EP0731099A1 (de) 1996-09-11
PT731099E (pt) 2000-11-30
UA46714C2 (uk) 2002-06-17
US6677372B2 (en) 2004-01-13
KR100405579B1 (ko) 2004-03-19
TW336934B (en) 1998-07-21
SV1996000015A (es) 1997-02-17
EE03921B1 (et) 2002-12-16
FI960998A7 (fi) 1996-09-07
MA23815A1 (fr) 1996-10-01
SI0731099T1 (en) 2000-08-31
ES2147320T3 (es) 2000-09-01
NO960884L (no) 1996-09-09
FI960998A0 (fi) 1996-03-04
AU4582896A (en) 1996-09-19

Similar Documents

Publication Publication Date Title
ATE193704T1 (de) N-(3-benzofuranyl)harnstoffderivate
TR199501209A2 (tr) Urea türevleri
DE69720051D1 (de) Harnstoffderivate
DE69611361D1 (de) Chinazolin-derivate
DE69522717D1 (de) Chinazolinderivate
NO974103L (no) Arylsulfonylaminohydroksamsyre-derivater
DE69610698D1 (de) Chinazolin-derivate
ATE260243T1 (de) N-aroylphenylalaninderivate
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
NO964667D0 (no) Purin-6-on-derivater
DE69601527D1 (de) Pyrrolylbenzimidazol-Derivate
ATA100695A (de) Prothrombin-derivate
DE69627830D1 (de) Pyrazol-derivate
DE69628200D1 (de) Diarylalkenylamin-derivate
DE59607054D1 (de) 4-Amino-benzoylguanidin-Derivate
DE59610106D1 (de) Fluorbenzylether-Derivate
ATE177102T1 (de) Chromanderivate
ATE225347T1 (de) Aza-anthracyclinone-derivate
NO983918D0 (no) Nye ureaderivater
DE59607055D1 (de) 4-Mercapto-benzoylguanidin-Derivate
NO975811D0 (no) Ny anvendelse for pyrrolderivater
DE69620514D1 (de) 5-aminoflavon-derivate
ATA45796A (de) Lysin-prolin-derivate
DE59603388D1 (de) Anilinderivate
TR199802513A3 (tr) N-(4- Karbamimido- fenil)- fenilglisinamid türevleri.

Legal Events

Date Code Title Description
MA Patent expired